Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Leukemia, apoptosis, Animal models, CLL, Non-Biological, cell division, Diseases, Lymphoma (any), Therapies, Elderly, Biological Processes, Technology and Procedures, Xenograft models, cytogenetics, epigenetics, gene editing, Study Population, Lymphoid Malignancies, Clinically relevant, genetic profiling, genomics, pharmacology, NGS, RNA sequencing, pathogenesis, WGS, pathways
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Leukemia, apoptosis, Animal models, CLL, Non-Biological, cell division, Diseases, Lymphoma (any), Therapies, Elderly, Biological Processes, Technology and Procedures, Xenograft models, cytogenetics, epigenetics, gene editing, Study Population, Lymphoid Malignancies, Clinically relevant, genetic profiling, genomics, pharmacology, NGS, RNA sequencing, pathogenesis, WGS, pathways
Monday, December 7, 2020: 11:30 AM-1:00 PM
Moderators:
Dimitar G Efremov, MD, PhD, International Center for Genetic Engineering and Biotechnology
and
Davide Rossi, MD, PhD, Istituto Oncologico della Svizzera Italiana (IOSI)
Disclosures:
Efremov: Janssen-Cilag International: Speakers Bureau. Rossi: Beigene: Honoraria; Janssen: Honoraria, Research Funding; AbbVie: Honoraria, Research Funding; AstraZenecs: Honoraria, Research Funding.
11:30 AM
11:45 AM
12:00 PM
12:15 PM
12:30 PM
12:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH